Back to search
PSR Ovarian Cancer With a BRCA Mutation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which PSR Ovarian Cancer With a BRCA Mutation trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which PSR Ovarian Cancer With a BRCA Mutation trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a single-arm, open label, expanded access program to provide access to olaparib tablets for relapsed high-grade epithelial ovarian cancer patients (incl…
Olaparib administered as monotherapy in the maintenance setting improves progression free survival compared to placebo in patients whose tumours carry loss of f…